Skip to main content
. 2022 Apr 25;9:875607. doi: 10.3389/fnut.2022.875607

TABLE 2.

Summary relative risk (RR) with 95% confidence interval (CI) of the association between high dietary acrylamide exposure and site-specific cancer.

All Never smoker Ever-smoker

Type of cancer N RR (95% CI) I2 N RR (95% CI) I2 N RR (95% CI) I2
Oral cavity 2 0.99 (0.67–1.46) 16.9 1 1.06 (0.84–1.33)
Oro and hypopharynx 1 0.61 (0.33–1.12)
Esophageal 5 1.05 (0.85–1.29) 25.5 3 1.22 (0.77–1.95) 36.2
Stomach 2 0.92 (0.82–1.05) 0.0 1 1.43 (0.92–2.23) 1 0.96 (0.60–1.53)
Colorectal 7 0.94 (0.87–1.02) 0.0 2 0.89 (0.46–1.73) 74.6 2 0.90 (0.64–1.26) 0.0
Colon 4 0.96 (0.85–1.09) 15.9 1 1.21 (0.86–1.70)
Rectal 4 0.99 (0.84–1.18) 0.0 1 1.48 (0.77–2.84)
Pancreatic 5 0.88 (0.77–1.02) 0.0 4 0.90 (0.74–1.10) 2.9 4 0.82 (0.65–1.03) 0.0
Liver 1 1.08 (0.87–1.34) 1 1.15 (0.85–1.56) 1 1.07 (0.80–1.43)
Head and neck 1 0.74 (0.50–1.09)
Laryngeal 2 1.10 (0.79–1.54) 0.0 1 0.82 (0.53–1.28)
Lung 2 0.91 (0.64–1.28) 83.1 2 0.92 (0.73–1.17) 0.0 2 1.16 (1.03–1.31) 0.0
Thyroid 1 1.33 (0.70–2.53) - 1 1.03 (0.84–1.26)
Bladder/Urothelial 3 0.89 (0.74–1.07) 0.0 3 0.85 (0.45–1.59) 72.5 3 0.94 (0.74–1.21) 0.0
Renal 7 1.08 (0.93–1.26) 19.4 4 1.13 (0.87–1.45) 0.0 3 1.10 (0.74–1.64) 0.0
Prostatic 7 1.00 (0.93–1.07) 0.0 4 0.98 (0.88–1.10) 0.0 4 0.96 (0.83–1.10) 0.0
Lymphoma 2 1.08 (0.95–1.22) 11.5 2 0.99 (0.68–1.44) 45.6 2 1.14 (0.81–1.62) 0.0
Multiple myeloma 2 0.97 (0.58–1.64) 63.6 2 0.98 (0.49–1.96) 50.5 1 0.52 (0.21–1.28)
Melanoma 1 1.18 (0.72–1.96) 1 1.14 (0.75–1.75)
Brain 1 0.87 (0.54–1.41) 1 0.87 (0.46–1.64)

Results are shown for all subjects and for never smokers and ever smokers separately.